Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Little is known about serological responses to MVA-BN (JYNNEOS) against mpox in elderly individuals with or without HIV. In this study, MVA-BN induced sustained IgG levels regardless of HIV status even up to one year. Birth before 1973 correlated with higher IgG. MVA-BN unvaccinated individuals with HIV had lower IgG than vaccinated.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11957076PMC
http://dx.doi.org/10.1101/2025.03.16.25324075DOI Listing

Publication Analysis

Top Keywords

unvaccinated individuals
8
individuals hiv
8
humoral immunity
4
immunity orthopoxvirus
4
orthopoxvirus vaccinated
4
vaccinated unvaccinated
4
individuals 2022
4
2022 mpox
4
mpox outbreak
4
outbreak serological
4

Similar Publications

Background: Seasonal vaccination campaigns against influenza and COVID-19 are critical for protecting vulnerable populations. Scientific evidence on past campaigns is essential for the effectiveness of future campaigns. This study aims to: (1) assess predictors of influenza and COVID-19 vaccination intentions (2) explore perceived barriers and facilitators of 2023-2024 seasonal vaccination campaign.

View Article and Find Full Text PDF

Objectives: Contribute to data on the long-term real-world effectiveness of the BNT162b2 vaccine efficacy (VE) in adolescents.

Study Design: This observational study from July 2021 to June 2022 was designed to emulate a target trial.

Methods: Fully vaccinated adolescents 12-15 years of age were matched to unvaccinated adolescents.

View Article and Find Full Text PDF

Existing inequities are exacerbated during the COVID-19 pandemic. Similar to HIV, COVID-19 disproportionately affects Black and other communities of color. Among Black women living with HIV (BWLWH) this study examined the relationship between community level and individual level social determinants of health and time to COVID-19 vaccine uptake.

View Article and Find Full Text PDF

Assessment of influenza vaccine effectiveness among the elderly in Taiwan using population-based registry data for the 2023-2024 season.

Vaccine

September 2025

Institute of Statistical Science, Academia Sinica. No.128, Academia Road, Section 2, Nankang, Taipei 11529, Taiwan; Institute of Epidemiology and Preventive Medicine, National Taiwan University, Room 501, No.17, Xu-Zhou Road, Taipei 100, Taiwan; Department of Mathematics, National Taiwan University.

Introduction: Influenza infection can cause serious complications in the elderly, including hospitalizations and death. In Taiwan, government-funded influenza vaccination is offered to the elderly ≥65 years old. We aim to evaluate vaccine effectiveness (VE) among this group during 2023-2024 influenza season using national databases.

View Article and Find Full Text PDF

Influenza vaccine effectiveness over 17 seasons in a large Japanese cohort: Analyses by age, virus type, underlying diseases and seasons before the COVID-19 pandemic.

J Infect Public Health

August 2025

Influenza Study Group of Japan Physicians Association, Tokyo Medical Association, Building 4F, 2-5 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-0062, Japan.

Background: As populations age and influenza reemerges post-COVID-19, evaluating vaccine effectiveness (VE) across age groups, comorbidities, virus types, and seasons is increasingly important.

Methods: A prospective multicenter cohort study was conducted annually by the Japan Physicians Association. Outpatients were registered with vaccination status before each influenza season and reported rapid antigen test results afterward.

View Article and Find Full Text PDF